RARE Drug Development Symposium: Repurposing in Rare Disease
December 15, 2020
Day 1: Dr. David Fajgenbaum and Dr. Bruce Bloom discuss why drug repurposing can provide hope for many rare disease patients seeking a diagnosis. They discuss the benefits, best practices, and strategies for effectively repurposing FDA approved therapies.
Drug repurposing experts Dr. David Fajgenbaum and Dr. Bruce Bloom discuss the many advantages of using FDA approved drug therapies for the treatment of multiple rare diseases, and offer tips on how to do it effectively.
Sign up for updates straight to your inbox.